Ras ssDNA aptamer inhibits vascular smooth muscle cell proliferation and migration through MAPK and PI3K pathways

Hu,Xiaoping; Wang,Zhiwei; Wu,Hongbing; Jiang,Wanli; Hu,Rui

doi:10.3892/ijmm.2015.2139

Ras ssDNA aptamer inhibits vascular smooth muscle cell proliferation and migration through MAPK and PI3K pathways

Authors:
- Xiaoping Hu
- Zhiwei Wang
- Hongbing Wu
- Wanli Jiang
- Rui Hu
View Affiliations

Affiliations: Department of Cardiovascular Surgery, Wuhan University Renmin Hospital, Wuhan, Hubei 430060, P.R. China
Published online on: March 16, 2015 https://doi.org/10.3892/ijmm.2015.2139
Pages: 1355-1361

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Proliferation and migration of vascular smooth muscle cells (VSMCs) mediated by Ras proteins are crucial in restenosis following percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). In this study, a novel, single‑stranded DNA (ssDNA) aptamer designated as Ras‑a1 with high affinity and specificity to human Ras protein was isolated using systematic evolution of ligands by exponential enrichment. Ras‑a1 was delivered into VSMCs by electroporation using one square waveform of 200 V for 20 msec. Proliferation of VSMCs was determined using a cell counting kit‑8 assay, which revealed the maximal inhibitory rate (40%) was obtained at 24 h after Ras‑a1 transfection. The migration of VSMCs, determined using a Transwell assay, was significantly inhibited in Ras‑a1 cells in a time‑dependent manner. To investigate the potential mechanisms of transfected Ras‑a1 on the migration and proliferation of VSMCs, the phosphorylation of MEK1/2, ERK1/2, and Akt was determined using western blot analysis, which showed that a marked downregulation was observed in the phosphorylation of MEK1/2, ERK1/2, and Akt following the delivery of Ras‑a1. This result demonstrated that Ras‑a1 inhibits the proliferation and migration of VSMCs by inhibiting the phosphorylation of Ras and interrupting signal transduction in the Ras‑MEK1/2‑ERK1/2 and phosphoinositide‑3 kinase/Akt pathways. The novel Ras protein‑targeted ssDNA aptamer selected may be applicable for the prevention of restenosis after PCI and CABG.

View Figures

View References

1	Shahabuddin S, Sami SA, Ansari JA, et al: Coronary artery bypass grafting after percutaneous coronary intervention. J Coll Physicians Surg Pak. 22:340–341. 2012.PubMed/NCBI
2	Abbate A, Biondi-Zoccai GG, Agostoni P, Lipinski MJ and Vetrovec GW: Recurrent angina after coronary revascularization: a clinical challenge. Eur Heart J. 28:1057–1065. 2007. View Article : Google Scholar : PubMed/NCBI
3	Wang Z, Zhang X, Chen S, et al: Lithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1α. PLoS One. 8:55471–55482. 2013. View Article : Google Scholar
4	Louis SF and Zahradka P: Vascular smooth muscle cell motility: From migration to invasion. Exp Clin Cardiol. 15:e75–e85. 2010.
5	Guo X, Chen KH, Guo Y, Liao H, Tang J and Xiao RP: Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 101:1113–1122. 2007. View Article : Google Scholar : PubMed/NCBI
6	Ramos KS: H-RAS controls phenotypic profiles of vascular smooth muscle cells and the pathogenesis of vascular proliferative disorders. Circ Res. 104:1139–1141. 2009. View Article : Google Scholar : PubMed/NCBI
7	Kong HY and Byun J: Nucleic acid aptamers: new methods for selection, stabilization, and application in biomedical science. Biomol Ther (Seoul). 21:423–434. 2013. View Article : Google Scholar
8	Chen CH, Chernis GA, Hoang VQ and Landgraf R: Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc Natl Acad Sci USA. 100:9226–9231. 2003. View Article : Google Scholar : PubMed/NCBI
9	Cerchia L, Duconge F, Pestourie C, et al: Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3:e1232005. View Article : Google Scholar : PubMed/NCBI
10	Bell C, Lynam E, Landfair DJ, Janjic N and Wiles ME: Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro. In Vitro Cell Dev Biol Anim. 35:533–542. 1999. View Article : Google Scholar : PubMed/NCBI
11	Lee PP, Ramanathan M, Hunt CA and Garovoy MR: An oligonucleotide blocks interferon-gamma signal transduction. Transplantation. 62:1297–1301. 1996. View Article : Google Scholar : PubMed/NCBI
12	Torres RA, Drake DA, Solodushko V, et al: Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation. Arterioscler Thromb Vasc Biol. 31:2424–2431. 2011. View Article : Google Scholar : PubMed/NCBI
13	Izumiya Y, Kim S, Izumi Y, et al: Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res. 93:874–883. 2003. View Article : Google Scholar : PubMed/NCBI
14	Indolfi C, Esposito G, Di Lorenzo E, et al: Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 92:1230–1235. 1995. View Article : Google Scholar : PubMed/NCBI
15	Deissler HL and Lang GE: Effect of VEGF165 and the VEGF aptamer pegaptanib (Macugen) on the protein composition of tight junctions in microvascular endothelial cells of the retina. Klin Monbl Augenheilkd. 225:863–867. 2008.In German. View Article : Google Scholar : PubMed/NCBI
16	Apte RS: Pegaptanib sodium for the treatment of age-related macular degeneration. Expert Opin Pharmacother. 9:499–508. 2008. View Article : Google Scholar : PubMed/NCBI
17	Mi Z, Guo H, Russell MB, Liu Y, Sullenger BA and Kuo PC: RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol Ther. 17:153–161. 2009. View Article : Google Scholar Sedding DG, Tröbs M, Reich F, et al: 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res. 104:1192–1200. 2009. View Article : Google Scholar : PubMed/NCBI
18	Sedding DG, Tröbs M, Reich F, Walker G, Fink L, Haberbosch W, Rau W, Tillmanns H, Preissner KT, Bohle RM, et al: 3-Deaza-adenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res. 104:1192–1200. 2009. View Article : Google Scholar : PubMed/NCBI
19	Jin G, Chieh-Hsi Wu J, Li YS, Hu YL, Shyy JY and Chien S: Effects of active and negative mutants of Ras on rat arterial neointima formation. J Surg Res. 94:124–132. 2000. View Article : Google Scholar : PubMed/NCBI
20	Isenović ER, Kedees MH, Tepavcevic S, et al: Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation. Cardiovasc Hematol Disord Drug Targets. 9:172–180. 2009. View Article : Google Scholar
21	Shen YJ, Zhu XX, Yang X, et al: Cardamonin inhibits angio-tensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phos-phorylation. J Nat Med. 3:623–629. 2014. View Article : Google Scholar
22	Shah BH, Neithardt A, Chu DB, Shah FB and Catt KJ: Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J Cell Physiol. 206:47–57. 2006. View Article : Google Scholar